Comparison between Akums Drugs IPO and Sanstar IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sanstar IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Sanstar IPO is up to ₹510.15 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Sanstar IPO is ₹95.00 per share.
| Akums Drugs IPO | Sanstar IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹90.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹95.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹95.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | |
| Market Lot Size | 22 shares | 150 shares |
| Fresh Issue Size | 1,00,37,708 shares | 4,18,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹397.10 Cr |
| OFS Issue Size | 1,73,30,435 shares | 1,19,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹113.05 Cr |
| Issue Size Total | 2,73,68,143 shares | 5,37,00,000 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹510.15 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Sanstar IPO opens on Jul 19, 2024. The closing date of Akums Drugs IPO and Sanstar IPO is Aug 01, 2024, and Jul 23, 2024, respectively.
| Akums Drugs IPO | Sanstar IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Jul 18, 2024 |
| Issue Open | Jul 30, 2024 | Jul 19, 2024 |
| Issue Close | Aug 01, 2024 | Jul 23, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Jul 24, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Jul 25, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Jul 25, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Jul 26, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Aug 23, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Oct 22, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Sanstar IPO P/E ratio of 19.98.
| Akums Drugs IPO | Sanstar IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | 99.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | 70.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1731.32 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | 30.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | 24.43% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | 0.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.75 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | 30.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Sanstar IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 1,07,40,000 shares in Sanstar IPO.
| Akums Drugs IPO | Sanstar IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 1,61,10,000 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 1,07,40,000 shares |
| NII | 40,68,637 shares | 80,55,000 shares |
| RII | 27,12,424 shares | 1,87,95,000 shares |
| Employee | 2,43,902 shares | |
| Others | ||
| Total | 2,73,68,151 shares | 5,37,00,000 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Sanstar IPO subscribed 82.99x.
| Akums Drugs IPO | Sanstar IPO | |
|---|---|---|
| QIB (times) | 90.09x | 145.68x |
| NII (times) | 42.10x | 136.49x |
| Big NII (times) | 47.43x | 149.44x |
| Small NII (times) | 31.45x | 110.61x |
| RII (times) | 20.80x | 24.23x |
| Employee (times) | 4.14x | |
| Other (times) | ||
| Total (times) | 63.44x | 82.99x |
